- Home
- AKRO vs EPR Comparison
AKRO vs EPR Comparison
Compare AKRO & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- EPR
- Stock Information
- Founded
- AKRO 2017
- EPR 1997
- Country
- AKRO United States
- EPR United States
- Employees
- AKRO N/A
- EPR N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- EPR Real Estate Investment Trusts
- Sector
- AKRO Health Care
- EPR Real Estate
- Exchange
- AKRO Nasdaq
- EPR Nasdaq
- Market Cap
- AKRO 3.7B
- EPR 4.4B
- IPO Year
- AKRO 2019
- EPR 1997
- Fundamental
- Price
- AKRO $53.97
- EPR $49.42
- Analyst Decision
- AKRO Buy
- EPR Buy
- Analyst Count
- AKRO 10
- EPR 10
- Target Price
- AKRO $73.56
- EPR $58.19
- AVG Volume (30 Days)
- AKRO 4.3M
- EPR 920.5K
- Earning Date
- AKRO 11-07-2025
- EPR 10-29-2025
- Dividend Yield
- AKRO N/A
- EPR 7.13%
- EPS Growth
- AKRO N/A
- EPR N/A
- EPS
- AKRO N/A
- EPR 2.29
- Revenue
- AKRO N/A
- EPR $707,150,000.00
- Revenue This Year
- AKRO N/A
- EPR $4.97
- Revenue Next Year
- AKRO N/A
- EPR $2.78
- P/E Ratio
- AKRO N/A
- EPR $21.72
- Revenue Growth
- AKRO N/A
- EPR 3.73
- 52 Week Low
- AKRO $21.34
- EPR $41.75
- 52 Week High
- AKRO $58.40
- EPR $61.24
- Technical
- Relative Strength Index (RSI)
- AKRO 67.48
- EPR 31.01
- Support Level
- AKRO $53.40
- EPR $48.11
- Resistance Level
- AKRO $54.31
- EPR $50.34
- Average True Range (ATR)
- AKRO 0.23
- EPR 1.18
- MACD
- AKRO -0.23
- EPR -0.41
- Stochastic Oscillator
- AKRO 66.30
- EPR 17.40
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About EPR EPR Properties
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.